COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.

Autor: Lin, Chung M A, Bennett, Josh, Rajagopala, Lavanya, Hunter, Ewan, Lorenzi, Alice R, Griffiths, Bridget, Baker, Kenneth F
Předmět:
Zdroj: Rheumatology; Jun2023, Vol. 62 Issue 6, pe185-e187, 3p
Abstrakt: The authors describe the characteristics, treatment and outcomes of treatment COVID-19 in non-hospitalized patients with rheumatic muskulosketal disease (RMD). Topics discussed include personalized clinical advice given to the patient, cohort characteristics and treatment, and clinical outcomes in the cohort.
Databáze: Complementary Index